Peter Mac Clinical Nurse Educator Trevor Saunders shares his nursing story and explains the new Nursing Professional Practice Model he was instrumental in developing.
“Scientists in the Clinic” has returned at Peter Mac after a COVID hiatus. For the remainder of the month, ten scientists will be embedded in clinical and other front-line hospital roles.
A Peter Mac clinical trial will expand internationally to include patients in Israel and the Middle East, in a sign of Peter Mac’s growing relationship with Sheba Medical Centre in Tel Aviv.
Art therapist Matilda (Tilly) Dawson is passionate about helping patients connect with their creativity. Having worked in oncology at the Royal Children’s Hospital since 2017, Tilly now divides her time between the two hospitals. Tilly utilises her Masters of Art Therapy and psycho-oncology...
A treatment pioneered at Peter Mac is emerging as the new standard of care for patients with inoperable kidney cancers. It involves a highly precise form of radiotherapy, and overturns previously held views that radiotherapy was not effective against kidney cancer. Peter Mac’s Associate Professor...
Associate Professor Paul Beavis, fundamental cancer researcher and immunologist at Peter Mac, has received a grant from the Cancer Council Victoria to look at ways to enhance the efficacy of a form of immune based cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell...
Cancer patients in Australia and the United States will benefit from a new research-focused collaboration between the Peter MacCallum Cancer Centre and Dana-Farber Cancer Institute in Boston. Through a Memorandum of Understanding (MOU), the institutions will explore potential areas of collaboration...
At the same time the pandemic placed a huge burden on hospital infection prevention teams, it triggered a rapid overhaul of the way they delivered training.
Peter Mac’s Chief Medical Officer Dr David Speakman and Director of Prevention and Wellbeing Geri McDonald joined the Hon. Ged Kearney MP, Assistant Minister for Health and Aged Care, at Parliament House in Canberra last Thursday for the official launch of the ‘Integrative Oncology and Wellness...
Peter MacCallum Cancer Centre and Cartherics Pty Ltd have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the treatment of cutaneous T-cell lymphoma (CTCL).